Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy

ClinicalTrials.gov ID: NCT03176472

Public ClinicalTrials.gov record NCT03176472. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 7:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, double-blind, 2-arm, parallel group study of up to 274 evaluable patients designed to evaluate the safety and efficacy of the histone deacetylase 6 (HDAC6) inhibitor ricolinostat for painful DPN.

Study identification

NCT ID
NCT03176472
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Regenacy Pharmaceuticals LLC
Industry
Enrollment
282 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 7, 2020 (Actual)
Primary completion
Oct 31, 2022 (Actual)
Completion
Apr 28, 2023 (Actual)
Last update posted
Sep 21, 2023

2020 – 2023

United States locations

U.S. sites
35
U.S. states
16
U.S. cities
33
Facility City State ZIP Site status
Pinnacle Research Group LLC Anniston Alabama 36207 —
Arizona Research Center Phoenix Arizona 85053 —
Diabetes/Lipid Management & Research Center Huntington Beach California 92648 —
National Research Institute Huntington Park California 90255 —
Altman Clinical and Translational Research Institute La Jolla California 92037 —
Torrance Clinical Research Institute Inc Lomita California 90717 —
Providence Clinical Research North Hollywood California 91606 —
Center for Clinical Research Inc San Francisco California 94115 —
Diablo Clinical Research Inc Walnut Creek California 94598 —
Innovative Research of West Florida Inc Clearwater Florida 33756 —
DeLand Clinical Research Unit Lake Mary Florida 32746 —
ClinCloud LLC Maitland Florida 32751 —
APF Research LLC Miami Florida 33134 —
International Research Associates LLC Miami Florida 33183 —
Sensible Healthcare LLC Ocoee Florida 34761 —
Progressive Medical Research Port Orange Florida 32127 —
Meridien Research Tampa Florida 33634 —
Metabolic Research Institute Inc West Palm Beach Florida 33401 —
Physicians Research Associates, LLC Lawrenceville Georgia 30046 —
Rocky Mountain Clinical Research Idaho Falls Idaho 83404 —
MediSphere Medical Research Center, LLC Evansville Indiana 47714 —
Tandem Clinical Research Marrero Louisiana 70072 —
Olive Branch Family Medical Center Olive Branch Mississippi 38654 —
Advanced Biomedical Research of America Las Vegas Nevada 89123 —
Hassman Research Institute Berlin New Jersey 08009 —
NY Scientific Brooklyn New York 11235 —
Triad Clinical Trials Greensboro North Carolina 27410 —
The Center for Clinical Research Winston-Salem North Carolina 27103 —
Coastal Carolina Research Center North Charleston South Carolina 29405 —
Palmetto Clinical Research Summerville South Carolina 29485 —
FutureSearch Trials of Neurology Austin Texas 78731 —
Nerve and Muscle Center of Texas Houston Texas 77030 —
Sun Research Institute San Antonio Texas 78215 —
Diabetes & Glandular Disease Clinic, P.A. San Antonio Texas 78229 —
Wasatch Clinical Research LLC Salt Lake City Utah 84107 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03176472, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 21, 2023 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03176472 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →